A new study raises new concerns about Zetia and Vytorin, drugs taken by millions of Americans to lower cholesterol. According to an article by the Associated Press on Philly.com, Zetia failed to shrink buildups in artery walls while a rival drug, Niaspan, did so significantly. Zetia users also suffered more heart attacks and other problems although the numbers of these events were too small to draw firm conclusions [...]
artery walls
Study on Merck Pill Zetia Raises New Questions
Posted in: Product Liability
Chelation Heart Disease Study Investigated by Government
The government is investigating if heart attack survivors enrolled in a controversial federal study of an alternative treatment were told about possible health risks.
According to this article, the $30 million study with 1,500 participants, is one of the largest alternative medicine experiments. It tests high doses of vitamin and mineral supplements and chelation, a treatment used for lead poisoning. It has not be [...]
Posted in: Medical Malpractice
